2020 Annual Meeting | C119 - Peripheral Neuropathy 3: Genetic Neuropathies: Molecular Diagnosis and Treatment Perspectives

��ɫ��

2020 Annual Meeting | C119 - Peripheral Neuropathy 3: Genetic Neuropathies: Molecular Diagnosis and Treatment Perspectives

Date Monday 04/27/20

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Mario A. Saporta, MD, PhD, FAAN

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should become familiar with the diagnostic work-up, including genetic testing, of inherited peripheral neuropathies and receive an update on new breakthroughs in therapy development in the field.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Audience Participation

Event Timeline
03:30 PM - 04:30 PM	Speaker	Genetic Neuropathies Through Clinical Cases Mario A. Saporta, MD, PhD, FAAN
04:30 PM - 05:00 PM	Speaker	Interpreting Molecular Testing in CMT: Best Practices and Challenges Mario A. Saporta, MD, PhD, FAAN
05:00 PM - 05:30 PM	Speaker	Therapy Development for Genetic Neuropathies: Current Stage and Perspectives John Svaren, PhD

Faculty Disclosures
Mario A. Saporta, MD, PhD, FAAN	Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SwanBio. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharnext. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therapeutics.
John Svaren, PhD	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��